Ítem
Solo Metadatos
PCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia
Título de la revista
Autores
Prieto, VA
Reyes, JM
Lopez-Cabra, C
Diaz, JA
Urrego-Novoa
Fecha
2016-05-01
Directores
ISSN de la revista
Título del volumen
Editor
Elsevier
Citations
Métricas alternativas
Resumen
Abstract
To estimate the cost-effectiveness of sunitinib as first-line treatment for metastatic renal-cell carcinoma (mRCC) from the Colombian health system perspective.
Palabras clave
Keywords
Public Health and Health Services , Medical and Health Sciences , Applied Economics , Economics